Literature DB >> 11251178

Significance of integrin alpha2/beta1 in peritoneal dissemination of a human gastric cancer xenograft model.

T Kawamura1, Y Endo, Y Yonemura, N Nojima, H Fujita, T Fujimura, T Obata, T Yamaguchi, T Sasaki.   

Abstract

In the present study, the role of integrin alpha2/beta1 in peritoneal dissemination of gastric cancer was investigated using an in vivo xenograft model for the highly metastatic MKN-45-P gastric cancer cells. Metastatic ability of MKN-45-P cells was significantly associated with the simultaneous expression of integrin alpha2 and alpha3 subunits. In an in vitro adhesion assay, neutralizing antibody for integrin alpha2 or beta1 subunit inhibited the adhesion of MKN-45-P cells to collagen type I and type IV. Moreover, the injection of anti-beta1 monoclonal antibody reduced the number of cancer cells on the peritoneum in nude mice that had been inoculated with MKN-45-P cells. These results suggest that integrin alpha2/beta1 represents a candidate target molecule available for the prevention of gastric cancer peritoneal dissemination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251178

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

1.  Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

Authors:  Erin S Haley; Gough G Au; Brian R Carlton; Richard D Barry; Darren R Shafren
Journal:  J Mol Med (Berl)       Date:  2009-01-13       Impact factor: 4.599

2.  Pathophysiology and biology of peritoneal carcinomatosis.

Authors:  Shigeki Kusamura; Dario Baratti; Nadia Zaffaroni; Raffaella Villa; Barbara Laterza; Maria Rosaria Balestra; Marcello Deraco
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

3.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

Authors:  Catherine C Park; Hui Zhang; Maria Pallavicini; Joe W Gray; Frederick Baehner; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

4.  Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.

Authors:  Faheem M Shaikh; Eric C Seales; William C Clem; Kristin M Hennessy; Ya Zhuo; Susan L Bellis
Journal:  Exp Cell Res       Date:  2008-07-30       Impact factor: 3.905

Review 5.  Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis.

Authors:  Katharine L Sodek; K Joan Murphy; Theodore J Brown; Maurice J Ringuette
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

Review 6.  Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements.

Authors:  Su Shao; Xue Yang; You-Ni Zhang; Xue-Jun Wang; Ke Li; Ya-Long Zhao; Xiao-Zhou Mou; Pei-Yang Hu
Journal:  Front Mol Biosci       Date:  2022-02-28

7.  A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: analysis of the mechanism of peritoneal dissemination using cDNA macroarrays.

Authors:  H Nomura; H Nishimori; T Yasoshima; F Hata; K Sogahata; H Tanaka; F Nakajima; S Ikeda; K Kamiguchi; H Isomura; N Sato; R Denno; K Hirata
Journal:  Jpn J Cancer Res       Date:  2001-07

8.  Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats.

Authors:  Danyan Li; Luqing Zhao; Yuxin Li; Xiuhong Kang; Shengsheng Zhang
Journal:  Drug Des Devel Ther       Date:  2020-06-09       Impact factor: 4.162

9.  Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration.

Authors:  Katharine L Sodek; Theodore J Brown; Maurice J Ringuette
Journal:  BMC Cancer       Date:  2008-08-05       Impact factor: 4.430

Review 10.  Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.

Authors:  Nina Sluiter; Erienne de Cuba; Riom Kwakman; Geert Kazemier; Gerrit Meijer; Elisabeth Atie Te Velde
Journal:  Clin Exp Metastasis       Date:  2016-04-13       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.